248 related articles for article (PubMed ID: 8459875)
21. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
22. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ
Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702
[TBL] [Abstract][Full Text] [Related]
23. Impaired initial cell reaction in CAPD-related peritonitis.
Koopmans JG; Boeschoten EW; Pannekeet MM; Betjes MG; Zemel D; Kuijper EJ; Krediet RT
Perit Dial Int; 1996; 16 Suppl 1():S362-7. PubMed ID: 8728224
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium.
Piraino B; Bernardini J; Holley JL; Perlmutter JA
Am J Kidney Dis; 1992 Apr; 19(4):371-4. PubMed ID: 1562027
[TBL] [Abstract][Full Text] [Related]
25. Peritoneal dialysate IgG/C3 levels do not predict susceptibility to peritonitis.
Anwar N; Hutchison AJ; Manos J; Uttley L; Brenchley P; Gokal R
Perit Dial Int; 1996; 16(2):154-7. PubMed ID: 9147549
[TBL] [Abstract][Full Text] [Related]
26. Decreased size of peritoneal macrophage during peritonitis in continuous ambulatory peritoneal dialysis patients.
Chen WT; Kobayashi Y; Huang TP; Chiu CC; Lin CY
Am J Nephrol; 1991; 11(5):374-9. PubMed ID: 1809034
[TBL] [Abstract][Full Text] [Related]
27. Specific increase in interleukin-8 concentrations in dialysis fluid of patients with peritonitis receiving continuous ambulatory peritoneal dialysis.
Ko YC; Mukaida N; Kasahara T; Muto S; Matsushima K; Kusano E; Asano Y; Itoh Y; Yamagishi Y; Kawai T
J Clin Pathol; 1995 Feb; 48(2):115-9. PubMed ID: 7745108
[TBL] [Abstract][Full Text] [Related]
28. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733
[TBL] [Abstract][Full Text] [Related]
29. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
Wang HH; Lin CY
Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis.
Mlambo NC; Hylander B; Brauner A
Inflammation; 1999 Apr; 23(2):131-9. PubMed ID: 10213269
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
[TBL] [Abstract][Full Text] [Related]
34. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
[TBL] [Abstract][Full Text] [Related]
35. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
[TBL] [Abstract][Full Text] [Related]
36. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
Lin CY; Huang TP
Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
[TBL] [Abstract][Full Text] [Related]
39. Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients?
Coles GA; Minors SJ; Horton JK; Fifield R; Davies M
Perit Dial Int; 1989; 9(1):69-72. PubMed ID: 2488186
[TBL] [Abstract][Full Text] [Related]
40. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Møller JK; Hagelskjaer LH
Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
